Baird analyst David Koning lowered the firm’s price target on Concentrix (CNXC) to $62 from $75 and keeps an Outperform rating on the shares. The firm updated its estimates following mixed Q3 results.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNXC:
- Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
- Concentrix falls -9.8%
- Trump threatens new tariffs on drugs, kitchen cabinets, trucks: Morning Buzz
- Concentrix falls -10.4%
- Morning Movers: Pharma, truck stocks react to Trump tariff announcements